A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

January 1, 2024

Conditions

Esophageal Cancer

Interventions

OTHER

no intervention

Trial Locations (1)

Renmin hosptial of Wuhan University, Wuhan

All Listed Sponsors

lead

Renmin Hospital of Wuhan University

OTHER

NCT06219031 - A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer | Biotech Hunter | Biotech Hunter